Cas no 179993-05-6 (1-(2-methoxyethyl)indole-3-carboxylic acid)
1-(2-methoxyethyl)indole-3-carboxylic acid Chemical and Physical Properties
Names and Identifiers
-
- 1-(2-Methoxy-ethyl)-1H-indole-3-carboxylic acid
- 1-(2-Methoxyethyl)-1H-indole-3-carboxylic acid
- 1-(2-methoxyethyl)indole-3-carboxylic acid
- 1-(2-methoxyethyl)-3-indolecarboxylic acid
- AKOS000111842
- HMS1704J19
- A881164
- DB-328430
- STL371906
- 179993-05-6
- MFCD07400598
- BBL025650
- EN300-54670
- A50850
- ALBB-028630
- CS-0216686
- Z274711532
- VS-08040
- CCG-124638
- SCHEMBL6042188
- 1-(2-methoxyethyl)-1H-indole-3-carboxylicacid
- 1H-Indole-3-carboxylic acid, 1-(2-methoxyethyl)-
-
- MDL: MFCD07400598
- Inchi: 1S/C12H13NO3/c1-16-7-6-13-8-10(12(14)15)9-4-2-3-5-11(9)13/h2-5,8H,6-7H2,1H3,(H,14,15)
- InChI Key: FXSBCLSDWGBWQY-UHFFFAOYSA-N
- SMILES: O(C)CCN1C=C(C(=O)O)C2C=CC=CC1=2
Computed Properties
- Exact Mass: 219.08954328g/mol
- Monoisotopic Mass: 219.08954328g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 16
- Rotatable Bond Count: 4
- Complexity: 257
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.3
- Topological Polar Surface Area: 51.5?2
Experimental Properties
- Density: 1.2±0.1 g/cm3
- Boiling Point: 420.3±25.0 °C at 760 mmHg
- Flash Point: 208.0±23.2 °C
- Vapor Pressure: 0.0±1.0 mmHg at 25°C
1-(2-methoxyethyl)indole-3-carboxylic acid Security Information
- Signal Word:warning
- Hazard Statement: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)
1-(2-methoxyethyl)indole-3-carboxylic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A199007164-1g |
1-(2-Methoxyethyl)-1H-indole-3-carboxylic acid |
179993-05-6 | 95% | 1g |
$305.76 | 2022-04-02 | |
| Fluorochem | 060020-250mg |
1-(2-Methoxy-ethyl)-1H-indole-3-carboxylic acid |
179993-05-6 | 95+% | 250mg |
£160.00 | 2022-03-01 | |
| Fluorochem | 060020-1g |
1-(2-Methoxy-ethyl)-1H-indole-3-carboxylic acid |
179993-05-6 | 95+% | 1g |
£372.00 | 2022-03-01 | |
| Fluorochem | 060020-2g |
1-(2-Methoxy-ethyl)-1H-indole-3-carboxylic acid |
179993-05-6 | 95+% | 2g |
£598.00 | 2022-03-01 | |
| Matrix Scientific | 034068-500mg |
1-(2-Methoxy-ethyl)-1H-indole-3-carboxylic acid |
179993-05-6 | 500mg |
$200.00 | 2023-09-09 | ||
| Chemenu | CM127809-1g |
1-(2-methoxyethyl)-1H-indole-3-carboxylic acid |
179993-05-6 | 95% | 1g |
$275 | 2021-08-05 | |
| TRC | M139543-25mg |
1-(2-methoxyethyl)-1H-indole-3-carboxylic Acid |
179993-05-6 | 25mg |
$ 50.00 | 2022-06-04 | ||
| TRC | M139543-50mg |
1-(2-methoxyethyl)-1H-indole-3-carboxylic Acid |
179993-05-6 | 50mg |
$ 70.00 | 2022-06-04 | ||
| TRC | M139543-250mg |
1-(2-methoxyethyl)-1H-indole-3-carboxylic Acid |
179993-05-6 | 250mg |
$ 295.00 | 2022-06-04 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 034068-500mg |
1-(2-Methoxy-ethyl)-1H-indole-3-carboxylic acid |
179993-05-6 | 500mg |
3251.0CNY | 2021-07-06 |
1-(2-methoxyethyl)indole-3-carboxylic acid Related Literature
-
Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
-
Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
-
Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
-
Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
Additional information on 1-(2-methoxyethyl)indole-3-carboxylic acid
Professional Introduction to 1-(2-methoxyethyl)indole-3-carboxylic Acid (CAS No. 179993-05-6)
1-(2-methoxyethyl)indole-3-carboxylic acid, a compound with the chemical identifier CAS No. 179993-05-6, is a significant molecule in the field of pharmaceutical chemistry and bioorganic synthesis. This compound, characterized by its indole core structure functionalized with a methoxyethyl side chain, has garnered considerable attention due to its versatile applications in drug discovery and molecular research. The unique structural features of 1-(2-methoxyethyl)indole-3-carboxylic acid make it a valuable scaffold for designing novel bioactive molecules.
The indole moiety is a prominent structural motif in numerous pharmacologically active compounds, including several well-known pharmaceuticals that exhibit a wide range of biological activities such as antimicrobial, anti-inflammatory, and anticancer properties. The presence of the methoxyethyl group in the molecule introduces additional functional diversity, enabling further chemical modifications and derivatization to tailor its pharmacological profile. This flexibility has made 1-(2-methoxyethyl)indole-3-carboxylic acid a popular choice for medicinal chemists seeking to develop new therapeutic agents.
In recent years, there has been a surge in research focused on indole derivatives as potential therapeutic candidates. The structural framework of indole provides a rich platform for modulating biological activity through various chemical transformations. Specifically, the carboxylic acid group in 1-(2-methoxyethyl)indole-3-carboxylic acid allows for facile coupling with amines via amide bond formation, a common strategy in drug design to enhance solubility and bioavailability. This property has been exploited in the synthesis of peptide mimetics and protein-protein interaction inhibitors, which are crucial for treating complex diseases.
Moreover, the methoxyethyl substituent in 1-(2-methoxyethyl)indole-3-carboxylic acid contributes to the compound's lipophilicity, which is a critical factor in determining its membrane permeability and cellular uptake. This balance between hydrophilicity and lipophilicity is often optimized in drug development to ensure efficient delivery to target sites within the body. Recent studies have demonstrated that modifications at this position can significantly influence the pharmacokinetic properties of indole-based drugs, making 1-(2-methoxyethyl)indole-3-carboxylic acid a promising intermediate in this context.
The compound's relevance extends beyond its use as a synthetic intermediate. It has been investigated as a potential precursor in the development of novel ligands for receptor binding studies. Indole derivatives are known to interact with various biological targets, including G-protein coupled receptors (GPCRs) and nuclear receptors, which play pivotal roles in regulating physiological processes. The structural versatility of 1-(2-methoxyethyl)indole-3-carboxylic acid allows researchers to fine-tune its interactions with these targets by introducing additional functional groups or altering the substitution pattern.
In the realm of synthetic chemistry, 1-(2-methoxyethyl)indole-3-carboxylic acid serves as an excellent building block for constructing more complex molecules through cross-coupling reactions such as Suzuki-Miyaura and Buchwald-Hartwig couplings. These reactions enable the introduction of aryl or heteroaryl groups at various positions of the indole ring, expanding the chemical space available for drug discovery. The ability to perform such transformations efficiently makes 1-(2-methoxyethyl)indole-3-carboxylic acid an indispensable tool in modern synthetic methodologies.
The pharmaceutical industry has also explored derivatives of 1-(2-methoxyethyl)indole-3-carboxylic acid as potential treatments for neurological disorders. Indole-based compounds have shown promise in modulating neurotransmitter systems and have been investigated for their potential role in managing conditions such as Alzheimer's disease and Parkinson's disease. The methoxyethyl group enhances metabolic stability while maintaining sufficient lipophilicity for blood-brain barrier penetration, making it an attractive feature for central nervous system (CNS) drug development.
In conclusion, 1-(2-methoxyethyl)indole-3-carboxylic acid (CAS No. 179993-05-6) is a multifaceted compound with significant implications in pharmaceutical research and drug development. Its unique structural features provide a versatile platform for designing bioactive molecules with diverse pharmacological profiles. The ongoing research into indole derivatives continues to uncover new applications and therapeutic potentials, reinforcing the importance of compounds like 1-(2-methoxyethyl)indole-3-carboxylic acid in advancing medical science.
179993-05-6 (1-(2-methoxyethyl)indole-3-carboxylic acid) Related Products
- 27018-76-4(1-benzyl-1H-indole-3-carboxylic acid)
- 132797-91-2(1-Ethyl-1H-indole-3-carboxylic acid)
- 351015-73-1(Methyl (3-Formyl-1H-indol-1-yl)acetate)
- 1313266-91-9(1-(2-Methoxyethyl)-1H-pyrrolo[2,3-c]pyridine-3-carboxylic acid)
- 1404532-03-1(1-(2-methoxy-2-oxoethyl)-5-methyl-1H-indole-3-carboxylic acid)
- 151409-82-4(1-(2-methoxyethyl)-1H-indole-3-carbaldehyde)
- 885524-96-9(1H-INDOLE-3-CARBOXYLIC ACID, 1-ETHYL-, ETHYL ESTER)
- 1313042-16-8(1-(2-Hydroxy-ethyl)-7-methyl-1H-indole-3-carboxylic acid)
- 943109-31-7(1-(2-hydroxyethyl)-1H-Indole-3-carboxylic acid)
- 141102-07-0(1-propyl-1H-indole-3-carboxylic acid)